跳至主要内容
临床试验/NCT07448753
NCT07448753Enrolling By Invitation不适用

Diagnostic Yield of ACTG2 and FLNA Gene Assessment in Adult Patients With Idiopathic Chronic Intestinal Pseudo-Obstruction and Reduced or Absent Distal Esophageal Contractility

Marina Coletta1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年9月17日最近更新:

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
20
试验地点
1
主要终点
The prevalence of mutations of ACTG2 or FLNA genes in a subgroup of patients with idiopathic CIPO with a myopathic phenotype revealed by reduced or absent distal esophageal contractility evaluated with high resolution esophageal manometry

研究概览

简要总结

To assess the diagnostic yield of Sanger sequencing for ACTG2 and FLNA genes evaluation on blood or saliva sample in patients with idiopathic CIPO in which high-resolution esophageal manometry (HRM) shows reduced (DCI <450 mmHg*s*cm) or absent distal esophageal contractility.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Male or female
  • Primary chronic intestinal pseudo-obstruction (CIPO)
  • Reduced (DCI < 450 mmHg·s·cm) or absent distal esophageal contractility on high-resolution manometry (HRM)

排除标准

  • Secondary CIPO
  • Primary CIPO due to an autoimmune/inflammatory disorder, evidenced by the presence of any of the following antibodies:
  • anti-gAChR

结局指标

主要结局

The prevalence of mutations of ACTG2 or FLNA genes in a subgroup of patients with idiopathic CIPO with a myopathic phenotype revealed by reduced or absent distal esophageal contractility evaluated with high resolution esophageal manometry

时间窗: October 2025-October 2026

次要结局

未报告次要终点

研究者

发起方
Marina Coletta
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Marina Coletta

Medical Doctor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

研究点 (1)

Loading locations...

相似试验

ACTG2/FLNA Testing Yield in Adult Idiopathic Chronic... | 临床试验